10:27 EDT Summit Therapeutics (SMMT) up 1% after report on AstraZeneca (AZN) partnership talks
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- AstraZeneca discussing $15B partnership with Summit Therapeutics, Bloomberg says
- Summit Therapeutics trading resumes
- Summit Therapeutics in talks for $15B AstraZeneca partnership, Bloomberg says
- Summit Therapeutics trading halted, volatility trading pause
- Strategic Collaboration and Growth Potential Drive Positive Outlook for Summit Therapeutics